pI: 8.319 |
Length (AA): 475 |
MW (Da): 53572 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | Procyclic, Bloodstream Form. | Siegel TN |
Siegel TN | Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites. |
Ortholog group members (OG5_128090)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G41770 | putative crooked neck protein / cell cycle protein |
Arabidopsis thaliana | AT3G13210 | putative crooked neck protein / cell cycle protein |
Arabidopsis thaliana | AT5G45990 | putative crooked neck protein / cell cycle protein |
Arabidopsis thaliana | AT3G51110 | Half-A-TPR repeat-containing protein |
Babesia bovis | BBOV_III004750 | tetratricopeptide repeat domain containing protein |
Brugia malayi | Bm1_50550 | Crooked neck-like protein 1 |
Candida albicans | CaO19.7964 | similar to factor involved in both pre-mRNA splicing and cell cycle progression |
Candida albicans | CaO19.332 | similar to factor involved in both pre-mRNA splicing and cell cycle progression |
Caenorhabditis elegans | CELE_M03F8.3 | Protein M03F8.3, isoform B |
Cryptosporidium hominis | Chro.70412 | hypothetical protein |
Cryptosporidium parvum | cgd7_3690 | crooked neck protein HAT repeats |
Dictyostelium discoideum | DDB_G0278819 | HAT repeat-containing protein |
Drosophila melanogaster | Dmel_CG3193 | crooked neck |
Echinococcus granulosus | EgrG_000844800 | crooked neck pre mRNA splicing factor 1 |
Entamoeba histolytica | EHI_175230 | crooked neck protein, putative |
Echinococcus multilocularis | EmuJ_000844800 | crooked neck pre mRNA splicing factor 1 |
Homo sapiens | ENSG00000101343 | crooked neck pre-mRNA splicing factor 1 |
Leishmania braziliensis | LbrM.35.4530 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_364490.1 | hypothetical protein, conserved |
Leishmania infantum | LinJ.36.4490 | hypothetical protein, conserved |
Leishmania major | LmjF.36.4280 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.36.4280 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_03190 | crooked neck |
Mus musculus | ENSMUSG00000001767 | Crn, crooked neck-like 1 (Drosophila) |
Neospora caninum | NCLIV_037180 | hypothetical protein |
Oryza sativa | 4338298 | Os05g0289400 |
Oryza sativa | 4348330 | Os10g0328700 |
Oryza sativa | 9268891 | Os06g0523800 |
Plasmodium berghei | PBANKA_1001400 | pre-mRNA-splicing factor CLF1, putative |
Plasmodium falciparum | PF3D7_0403700 | pre-mRNA-splicing factor CLF1, putative |
Plasmodium knowlesi | PKNH_0301700 | pre-mRNA-splicing factor CLF1, putative |
Plasmodium vivax | PVX_001060 | splicing factor, putative |
Plasmodium yoelii | PY02447 | hypothetical protein |
Saccharomyces cerevisiae | YLR117C | Clf1p |
Schistosoma japonicum | Sjp_0048020 | Crooked neck-like protein 1, putative |
Schistosoma mansoni | Smp_148230 | Pre-mRNA-splicing factor CLF1 |
Schmidtea mediterranea | mk4.007501.00 | Crooked neck-like protein 1 |
Schmidtea mediterranea | mk4.001551.03 | Crooked neck-like protein 1 |
Trypanosoma brucei gambiense | Tbg972.10.11820 | hypothetical protein, conserved |
Trypanosoma brucei | Tb11.v5.0735 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.10.9660 | Splicing factor CRN, putative |
Trypanosoma congolense | TcIL3000_10_8690 | HAT (Half-A-TPR) repeats, putative |
Trypanosoma cruzi | TcCLB.504147.320 | hypothetical protein, conserved |
Toxoplasma gondii | TGME49_269200 | crooked neck family 1 protein isoform 2, putative |
Theileria parva | TP02_0476 | crooked neck protein, putative |
Trichomonas vaginalis | TVAG_139790 | crooked neck protein, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.9660 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.9660 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.9660 | Trypanosoma brucei | significant gain of fitness in procyclic forms | alsford |
Tb927.10.9660 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_M03F8.3 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_M03F8.3 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_M03F8.3 | Caenorhabditis elegans | sterile | wormbase |
YLR117C | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_1001400 | Plasmodium berghei | Essential | plasmo |
TGME49_269200 | Toxoplasma gondii | Probably essential | sidik |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.